

T8376 · 1 x 106 cells / 1.0 mL
abm good · Cat: T8376
Reach 3+ verified distributors
Manufacturer product page
abmgood.com/ku19-19mmctxr-cell-line-t8376.html
Description
The KU19-19/MMC/TXR cell line is a multidrug-resistant subline derived from the human bladder carcinoma parent line KU19-19. This variant has been developed through sequential exposure to mitomycin C MMC followed by paclitaxel TXR , resulting in a robust in vitro model for studying resistance mechanisms to DNA crosslinking agents and microtubule-targeting chemotherapeutics.







